Endovascular treatment is a highly effective therapy for acute ischemic stroke due to large
vessel occlusion. However, in clinical practice, nearly half of the patients do not have …

Myocardial infarction is one of the primary causes of mortality in patients with coronary heart
disease worldwide. Early treatment of acute myocardial infarction restores blood supply of …

Background and Objectives The relevance of impaired microvascular tissue-level
reperfusion despite complete upstream macrovascular angiographic reperfusion (no-reflow) …

Primary percutaneous angioplasty (pPCI), represents the reperfusion strategy of choice for
patients with STEMI according to current international guidelines of the European Society of …

There is a lack of understanding in the cardiac remodeling field regarding the use of
nonreperfused myocardial infarction (MI) and reperfused MI in animal models of MI. This …

Background and Objectives. The no-reflow phenomenon is a poor prognosis for patients
with ST-elevation myocardial infarction (STEMI) who underwent percutaneous coronary …

Coronary artery no-reflow is a complex problem in the area of reperfusion therapy, and the
molecular mechanisms underlying coronary artery no-reflow injury have not been fully …

This study aimed to evaluate the relationship between no-reflow phenomenon and systemic
inflammation index (SII) and to compare the predictive capacity of SII together with the …

Systemic immune-inflammation index (SII), which is a good predictive marker for coronary
artery disease, can be calculated by using platelet, neutrophil, and lymphocyte counts. The …

Both skin wound healing and the cardiac response to myocardial infarction (MI) progress
through similar pathways involving inflammation, resolution, tissue repair, and scar …